FDA issues ventilator recall

Philips Respironics has recalled certain V60 and V60 Plus ventilators due to an expired adhesive, the Food and Drug Administration (FDA) announced this week. This is a Class 1 recall, the most serious type, indicating ventilators could cause serious injury or death. In other actions, the FDA issued a Letter to Health Care Personnel this week providing conservation strategies for prefilled 0.9% sodium chloride IV lock/ flush syringes. Earlier in the month, the FDA extended the shelf life of the Johnson & Johnson COVID-19 vaccine from six to nine months. On April 6, an FDA advisory panel will meet to discuss requests by Pfizer and Moderna to make a second booster dose of their vaccines available to adults over age 65 and to all adults, respectively.